==Titletests (default, INN, drug_name)==
===Lysergide (LSD)===
{{Purge}} Reduced infobox.
:Current infobox title: {{strong|1=Lysergic acid diethylamide}} (pagename, not INN)
:New situation would be (adding "(LSD)" is just a liberty I took, to help our readers):
{{Testcase table
| drug_name=Lysergic acid diethylamide (LSD)
| INN = Lysergide
| IUPAC_name = (6a''R'',9''R'')-''N'',''N''-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-''fg'']quinoline-9-carboxamide
| image = LSD-2D-skeletal-formula-and-3D-models.png
<!--Clinical data-->
| pregnancy_US = C
| legal_AU = Schedule 9
| legal_CA = Schedule III
| legal_NZ = Class A
| legal_UK = Class A
| legal_UN = P I
| legal_US = Schedule I
| legal_DE = Anlage I
| addiction_liability = None
| dependency_liability = Low
| routes_of_administration = [[Oral administration|Oral]], etc
<!--Pharmacokinetic data-->
| metabolism = Hepatic
| elimination_half-life = 3–5 hours
| excretion = [[Renal]]
<!--Identifiers-->
| CAS_number = 50-37-3
| ChEBI = 6605
| PubChem = 5761
| IUPHAR_ligand = 17
| DrugBank = DB04829
| ChemSpiderID = 5558
| UNII = 8NA5SWF92O
| ChEMBL = 263881
| ATC_prefix = none
<!--Chemical data-->
| C=20 | H=25 | N=3 | O=1
| synonyms = Acid, LSD, lysergide
}}
=== (regular)===
* [[alpha-Methyltryptamine]]
: No need to use {{para|INN}}. Note the titletext (mousehover).
{{Testcase table
| IUPAC_name = 2-(1''H''-indol-3-yl)-1-methyl-ethylamine
| image = AMT.svg
| width = 150px
| drug_name = α-Methyltryptamine
<!--Clinical data-->
| routes_of_administration = [[Mouth|Oral]]
<!--Identifiers-->
| CAS_number = 299-26-3
| ATC_prefix = none
| ATC_suffix =
<!--Chemical data-->
| C=11 | H=14 | N=2
| synonyms = Indopan; IT-290, IT-403, U-14,164E, 3-IT
}}
===Default Title===
{{testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
}}
{{testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
}}
{{testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
}}
{{testcase table
| drug_name = Aspirin
| CAS_number = 1234-56-7
| trade_names=dn is diff
}}
==Test INN==
{{testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
| INN = inn
}}
{{testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
| INN = inn
}}
{{testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
| INN = inn
}}
{{testcase table
| drug_name = Aspirin [[Main page|MP]]
| CAS_number = 1234-56-7
| trade_names=dn is diff
| INN = inn
}}
;blanks
{{testcase table
| drug_name =
| CAS_number =
| trade_names=
| INN =
}}
===INN=none===
{{testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
}}
{{testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
}}
{{testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
}}
{{testcase table
| drug_name = Aspirin
| CAS_number = 1234-56-7
| trade_names=dn is diff
}}
===INN=some sense===
{{testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
| INN = inn
}}
{{testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
| INN = inn
}}
{{testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
| INN = inn
}}
{{testcase table
| drug_name = Aspirin
| CAS_number = 1234-56-7
| trade_names=dn is diff
| INN = inn
}}
===INN='none'===
{{testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
| INN = none
}}
{{testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
| INN = none
}}
{{testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
| INN = None
}}
{{testcase table
| drug_name = Aspirin
| CAS_number = 1234-56-7
| trade_names=dn is diff
| INN = none
}}
===INN eq===
{{testcase table
| drug_name = Infobox drug/testcases8
| INN = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
}}
==All blank==
{{testcase table
| no_param_name=99
}}
==All up==
{{purge}}
{{Testcase table
| type = IUPAC
| drug_name = 1/IUPAC
| captionLR = Cap LR
| imageL = L1 barcelona.svg
| imageR = Tabliczka_R1.svg
| widthL = 70px
| widthR = 90px
| altL = alt-L
| altR = alt-R
| Watchedfields = 103
| imagename = 2
| image = Racemic amphetamine 2.svg
| width = 175px
| alt = an example image
| image2 = D-Amphetamine-3D-balls.png
| width2 = 150px
| alt2 = another example image
| caption = some images
| IUPAC_name = 12
| trivial_name = some-name
| target = 13
| vaccine_type = Toxoid
| mab_type = F(ab')2
| source = xi/a
| component1 = 17
| class1 = 18
| component2 = 19
| class2 = 20
| component3 = 21
| class3 = 22
| component4 = 23
| class4 = 24
| tradename = 25
| tradename_pronunciation = twenty-five
| tradename_synonym = two dozen plus one
| Drugs.com = 27
| MedlinePlus = 29
| licence_CA = 29.5
| licence_EU = 30
| licence_US = 31
| DailyMedID = 32
| pregnancy_AU = B3
| pregnancy_US = C
| pregnancy_category = 35
| legal_AU = S4
| legal_CA = Schedule IV
| legal_UK = POM
| legal_US = Schedule III
| legal_UN = N II III
| legal_EU = Category 2 Precursor
| legal_status = RX
| dependency_liability = 43-1
| addiction_liability = 43-2
| routes_of_administration = 44
| bioavailability = 45
| protein_bound = 46
| metabolism = 47
| onset = 47.5
| elimination_half-life = 48
| excretion = 49
| CAS_number = 50
| CAS_number_Ref = 51
| CAS_supplemental = 52
| ATCvet = 53
| ATC_prefix = 54
| ATC_suffix = 55
| ATC_supplemental = 56
| PubChem = 57
| PubChemSubstance = 58
| IUPHAR_ligand = 59
| DrugBank = 60
| DrugBank_Ref = 101
| ChemSpiderID = 61
| ChemSpiderID_Ref = 62
| UNII = 63
| UNII_Ref = 64
| KEGG = 65
| KEGG_Ref = 66
| ChEBI = 67
| ChEBI_Ref = 68
| ChEMBL = 69
| ChEMBL_Ref = 70
| NIAID_ChemDB = 71
| synonyms = 72
| PDB_ligand = 73
| chemical_formula =
| C = 1
| H = 2
| Ag = 3
| Al = 4
| As = 5
| Au = 6
| B = 7
| Bi = 8
| charge = -1
| molecular_weight = 75
| show_all=yes
| smiles = 76
| StdInChI = 77
| StdInChI_comment = 78
| StdInChI_Ref = 79
| StdInChIKey = 80
| StdInChIKey_comment = 81
| StdInChIKey_Ref = 82
| density = 83
| melting_point = 84
| melting_high = 85
| melting_notes = 86
| boiling_point = 87
| boiling_high = 104
| boiling_notes = 88
| solubility = 89
| chirality = 106
| specific_rotation = 90
| sec_combustion = 91
| Verifiedfields = 92
| verifiedrevid = 93
}}
{{purge}} (reduced infobox)
:Current infobox title: {{strong|1= Diamorphine ({{abbr|INN|International Nonproprietary Name}})}}
: The new situation required an edit.
{{testcase table
| drug_name = Heroin
| INN = Diamorphine
| IUPAC_name = (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate
| image = Heroin - Heroine.svg
| image2 = Heroin-from-xtal-horizontal-3D-balls.png
<!--Clinical data-->
| pronounce = {{IPAc-en|ˈ|h|ɛ|r|o:|ɪ|n}}
| Drugs.com = {{drugs.com|parent|heroin}}
| legal_AU = S9
| dependency_liability = Physical: Very high<br />Psychological: Very high
| addiction_liability = Very high
| routes_of_administration = Inhalation, transmucosal, intravenous, oral, intranasal, rectal, intramuscular
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 561-27-3
| ATC_prefix = N07
| ATC_suffix = BC06
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 27808
| PubChem = 5462328
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01452
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4575379
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8H672SHT8E
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 459324
<!--Chemical data-->
| C=21 | H=23 | N=1 | O=5
| molecular_weight = 369.41 g/mol
| synonyms = Diamorphine, Diacetylmorphine, Acetomorphine, (Dual) Acetylated morphine, Morphine diacetate
}}
- 1 2 "Riboflavin". Drugs.com. 22 July 2021. සම්ප්රවේශය 8 October 2021.
- ↑ Liu TW, Chen LT (201). "S-1 with leucovorin for gastric cancer: how far can it go?". Lancet Oncol. 17 (1): 12–4. doi:10.1016/S1470-2045(15)00478-7. PMID 26640038.
- ↑ "Teysuno 20mg/5.8mg/15.8mg hard capsules - Summary of Product Characteristics (SmPC)". (emc). සම්ප්රවේශය 30 July 2020.
- ↑ Liu TW, Chen LT (201). "S-1 with leucovorin for gastric cancer: how far can it go?". Lancet Oncol. 17 (1): 12–4. doi:10.1016/S1470-2045(15)00478-7. PMID 26640038.
- ↑ "Teysuno 20mg/5.8mg/15.8mg hard capsules - Summary of Product Characteristics (SmPC)". (emc). සම්ප්රවේශය 30 July 2020.
